A peripheral circulating compartment of natural naive CD4+ Tregs

Journal of Clinical Investigation

Volumn 115, Issue 7, 2005, Pages 1953-1962

  Valmori, Danila ^a   Merlo, Andrea ^a   Souleimanian, Naira E ^a   Hesdorffer, Charles S ^a   Ayyoub, Maha ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREG CELL;

ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNITY, NATURAL; IMMUNOPHENOTYPING; L-SELECTIN; MICE; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-2; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS;

EID: 22144466887     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23963     Document Type: Article

References (42)

1. Jameson, S.C., and Bevan, M.J. 1998. T-cell selection. Curr. Opin. Immunol. 10:214-219.
2. - T cells. J. Clin. Invest. 112:1437-1443. doi:10.1172/JCI200319441.
3. Piccirillo, C.A., and Thornton, A.M. 2004. Corner-stone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells [review]. Trends Immunol. 25:374-380.
4. Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O., and Bandeira, A. 2001. On the ontogeny and physiology of regulatory T cells. Immunol. Rep. 182:5-17.
5. Jordan, M.S., et al. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-306.
6. Bach, J.F. 2003. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3:189-198.
7. Roncarolo, M.G., and Levings, M.K. 2000. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12:676-683.
8. Weiner, H.L. 2001. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat. Immunol. 2:671-672.
9. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing 1L-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
10. Murakami, M., Sakamoto, A., Bender, J., Kappler, J., and Marrack, P. 2002. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. U. S. A. 99:8832-8837.
11. Cohen, J.L., Trenado, A., Vasey, D., Klatzmann, D., and Salomon, B.L. 2002. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp. Med. 196:401-406.
12. Belkaid, Y., Piccirilio, C.A., Mendez, S., Shevach, E.M., and Sacks, D.L. 2002. CD4+CD25+ regulatory T cells control. Leishmania major persistence and immunity. Nature. 420:502-507.
13. Onizuka, S., et al. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 59:3128-3133.
14. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008-3018.
15. Taams, L.S., et al. 2001. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31:1122-1131.
16. Thornton, A.M., and Shevach, E.M. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
17. Thornton, A.M., and Shevach, E.M. 2000. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183-190.
18. Baecher-Allan, C., Brown, J.A., Freeman, G.J., and Hafler, D.A. 2001. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
19. Michie, C.A., McLean, A.R., Alcock, C., and Beverley, P.C.L. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 360:264-265.
20. Nakamura, K., et al. 2004. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 172:834-842.
21. Schwartz, R.H. 2005. Natural regulatory T cells and self-tolerance. Nat. Immunol. 6:327-330.
22. Romagnoli, P., Hudrisier, D., and van Meerwijk, J.P. 2002. Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J. Immunol. 168:1644-1648.
23. Tivol, E.A., et al. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
24. Leach, D.R., Krummel, M.F., and Allison, J.P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 271:1734-1736.
25. Kirman, J., et al. 1999. CTLA-4 blockade enhances the immune response induced by mycobacterial infection, but does not lead to increased protection. Infect. Immun. 67:3786-3792.
26. Takahashi, T., et al. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
27. Read, S., Malmstrom, V., and Powrie, F. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
28. Schubert, L.A., Jeffery, E., Zhang, Y., Ramsdell, F., and Ziegler, S.F. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:37672-37679.
29. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
30. Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
31. Wing, K., Ekmark, A., Karlsson, H., Rudin, A., and Suri-Payer, E. 2002. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology. 106:190-199.
32. Takahata, Y., et al. 2004. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset wich naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp. Hematol. 32:622-629.
33. Zheng, S.G., Wang, J.H., Gray, J.D., Soucier, H., and Horwitz, D.A. 2004. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172:5213-5221.
34. Sallusto, F., Lenig, D., Forster, R., Lipp, M., and Lanzavecchia, A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708-712.
35. Szanya, V., Ermann, J., Taylor, C., Holness, C., and Fathman, C.G. 2002. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-2465.
36. Iellem, A., et al. 2001. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194:847-853.
37. D'Ambrosio, D., Sinigaglia, F., and Adorini, L. 2003. Special attractions for suppressor T cells. Trends Immunol. 24:122-126.
38. Cyster, J.G. 2000. Leukocyte migration: scent of the T zone [review]. Curr. Biol. 10:R30-R33.
39. Godfrey, W.R., et al. 2005. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood. 105:750-758.
40. Stephens, L.A., Mottet, C., Mason, D., and Powrie, F. 2001. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31:1247-1254.
41. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338-344.
42. Douek, D.C., et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature. 396:690-695.